More J&J problems: vaccine production stopped and more possible clot cases
Enlarge / The Emergent BioSolutions plant, a manufacturing partner for Johnson & Johnson’s Covid-19 vaccine, in Baltimore, Maryland, on April 9, 2021. Covid-19 Coverage View more stories…
